News
While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as “chemo brain.” These effects ...
While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as "chemo brain." These effects ...
New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with ...
Brazilian scientists have identified a molecule, BamazScplp1, in Amazonian scorpion venom that effectively kills breast ...
Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the ...
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the safety and efficacy of ...
A molecule found in the venom of the Brotheas amazonicus scorpion showed similar characteristics to those of the chemotherapy ...
Cancer Research UK-funded scientists at the University of Cambridge create a test to predict resistance to chemotherapy. The test uses changes to cancer DNA at diagnosis to predict which patients will ...
The combination of relacorilant and nab-paclitaxel improved survival in platinum-resistant ovarian cancer following a break ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results